JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

Search

TPG Specialty Lending Inc

Закрыт

СекторФинансы

22.77 -0.61

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

22.64

Макс.

23.16

Ключевые показатели

By Trading Economics

Доход

22M

59M

Продажи

-1.5M

112M

P/E

Средняя по отрасли

11.388

27.54

Дивидендная доходность

9.16

Рентабельность продаж

52.464

EBITDA

23M

87M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+5.29% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

9.16%

3.88%

Следующий отчет о доходах

4 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-97M

2.2B

Предыдущая цена открытия

23.38

Предыдущая цена закрытия

22.77

Новостные настроения

By Acuity

100%

0%

503 / 529 Рейтинг в Finance

Техническая оценка

By Trading Central

Уверенность

Bearish Evidence

TPG Specialty Lending Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

28 окт. 2025 г., 23:50 UTC

Популярные акции

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28 окт. 2025 г., 23:25 UTC

Отчет

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28 окт. 2025 г., 23:18 UTC

Отчет

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28 окт. 2025 г., 22:20 UTC

Отчет

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28 окт. 2025 г., 22:13 UTC

Отчет

Wal-Mart de Mexico Net Profit Falls in 3Q

28 окт. 2025 г., 21:38 UTC

Отчет

Correction to Visa Sales Jump Article

28 окт. 2025 г., 21:17 UTC

Отчет

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28 окт. 2025 г., 21:07 UTC

Отчет

Visa Sales Jump as Consumers Keep Spending -- Update

28 окт. 2025 г., 21:02 UTC

Отчет

Mondelez Tempers Outlook as Costs Rise

28 окт. 2025 г., 23:51 UTC

Обсуждения рынка

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28 окт. 2025 г., 23:42 UTC

Обсуждения рынка

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28 окт. 2025 г., 23:02 UTC

Отчет

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28 окт. 2025 г., 23:01 UTC

Отчет

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28 окт. 2025 г., 22:46 UTC

Отчет

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28 окт. 2025 г., 22:45 UTC

Отчет

SK Hynix 3Q Net KRW12.6T >000660.SE

28 окт. 2025 г., 22:44 UTC

Отчет

SK Hynix 3Q Rev KRW24.44T >000660.SE

28 окт. 2025 г., 22:43 UTC

Отчет

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28 окт. 2025 г., 22:42 UTC

Отчет

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28 окт. 2025 г., 22:40 UTC

Отчет

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28 окт. 2025 г., 22:40 UTC

Отчет

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28 окт. 2025 г., 22:22 UTC

Отчет

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28 окт. 2025 г., 22:22 UTC

Отчет

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28 окт. 2025 г., 22:22 UTC

Отчет

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28 окт. 2025 г., 22:20 UTC

Отчет

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28 окт. 2025 г., 22:02 UTC

Отчет

Review & Preview: Earnings Extravaganza -- Barrons.com

28 окт. 2025 г., 21:42 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

28 окт. 2025 г., 21:42 UTC

Обсуждения рынка
Отчет

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28 окт. 2025 г., 21:20 UTC

Отчет

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28 окт. 2025 г., 21:19 UTC

Отчет

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28 окт. 2025 г., 21:18 UTC

Отчет

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Сравнение c конкурентами

Изменение цены

TPG Specialty Lending Inc Прогноз

Целевая цена

By TipRanks

5.29% рост

Прогноз на 12 месяцев

Средняя 24.1 USD  5.29%

Максимум 25 USD

Минимум 22 USD

Основано на мнении 10 аналитиков Wall Street, спрогнозировавших целевые цены для TPG Specialty Lending Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

10 ratings

8

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

20.83 / 21.65Поддержка и Сопротивление

Краткосрочная

Bearish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Bearish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании TPG Specialty Lending Inc

Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a business development company. The fund provides senior secured loans (first-lien, second-lien, and unitranche), unsecured loans, mezzanine debt, and investments in corporate bonds and equity securities and structured products, non-control structured equity, and common equity with a focus on co-investments for organic growth, acquisitions, market or product expansion, restructuring initiatives, recapitalizations, and refinancing. The fund invests in business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty related businesses, education, and specialty finance. It seeks to finance and lending to middle market companies principally located in the United States. The fund invests in companies with enterprise value between $50 million and $1 billion or more and EBITDA between $10 million and $250 million. The transaction size is between $15 million and $350 million. The fund invests across the spectrum of the capital structure and can arrange syndicated transactions of up to $500 million and hold sizeable positions within its credits.
help-icon Live chat